| Compound | Binding energy (kcal/mol) | H-bond interaction | Hydrophobic interaction | Number of interaction | Amino acid residues | Number of interaction | Amino acid residues |
| α-D-glucopyranose (co-crystallized ligand) | −5.7 | 4 | GLU277a, GLN279, ARG442 | — | — | Acarbose (standard drug) | −8.4 | 13 | LYS156, TYR158, SER241, ASP242a, GLU277, GLN279, HIS280, ARG315, HIS351, ASP352a, ARG442 | — | — | Pyranone | −5.3 | 1 | ASP352 | — | — | Malic acid | −5.4 | 3 | ASP215, GLU277, ARG442 | 1 | TYR72 | Pyrogallic acid | −5.9 | 7 | ARG213a, HIS351, ASP352a, ARG442a | 2 | PHE178, VAL216 | Palmitic acid | −6.1 | 1 | ARG446 | 8 | TYR72, TYR158, PHE159, PHE178a, VAL216, PHE303, ASP352 | Ethyl palmitate | −5.3 | — | — | 9 | TYR158b, PHE159, VAL216, PHE303a, ARG315, ASP352 | Linoleic acid | −6.5 | 2 | ASP215, ARG446 | 8 | TYR72, TYR158, PHE178, VAL216, PHE303a, ARG315, ASP352 | Linolenic acid | −6.8 | 3 | ARG213, ASP352, ARG446 | 8 | TYR72, TYR158, PHE159, VAL216, PHE303a, ASP352, ARG442 | Stearic acid | −6.5 | 2 | ASP352, ARG446 | 8 | TYR72, LYS156, TYR158b, PHE159, PHE178, ARG315 | Ethyl oleate | −6.0 | 1 | ARG315 | 8 | TYR72, PHE159, PHE178, VAL216, PHE303a, ARG315, ASP352 | Oleamide | −6.1 | 3 | SER241, ASP242a | 7 | LYS156, TYR158, PHE159, PHE303, PHE314a, ARG315 | Campesterin | −8.9 | 1 | GLU277 | 5 | TYR158a, PHE159, PHE303, ARG315 |
|
|